Critical Profitability Ratio Analysis under Limelight: Endologix, Inc. (NASDAQ:ELGX), ACADIA Pharmaceuticals (NASDAQ:ACAD)

Moving on tracing line, Endologix, Inc. (NASDAQ:ELGX) need to consider for profitability analysis, in latest session share price swings at $6.19 with percentage change of 7.09%.

The Co has negative -78.50% profit margins to find consistent trends in a firm’s earnings. Gross profit margins and operating profit margins are its sub parts that firm have 63.90% and -51.20% respectively. ELGX has returns on investment of -16.10%. The returns on assets were -38.50% that gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of -112.40%, which is measuring profitability by disclosing how much profit generates by ELGX with the shareholders’ money.

The firm attains analyst recommendation of 2.20 on scale of 1-5 with week’s performance of 9.68%. The firm current ratio calculated as 2.50, this value is acceptable if it lies in 1.3% to 3%. But its varies industry to industry. To strengthen these views, active industry firm has Quick Ratio of 1.70, which indicates firm has sufficient short-term assets to cover its immediate liabilities. In addition, the firm has debt to equity ratio of 1.31, sometimes its remain same with long term debt to equity ratio.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) also making a luring appeal, share price swings at $31.68 with percentage change of -0.81% in most recent trading session.

While returns on assets calculated as -54.70% hat gives an idea about how efficient management is at using its assets to generate earnings. It has returns on equity of -58.50%, which is measuring a corporation’s profitability by revealing how much profit generates by ACAD with the shareholders’ money. The firm attains analyst recommendation of 2.30 on scale of 1-5 with week’s performance of 10.33%.

Moving toward ratio analysis, it has current ratio of 15.40 and quick ratio was calculated as 15.30. The debt to equity ratio appeared as 0.00 for seeing its liquidity position. The firm attains analyst recommendation of 2.30 out of 1-5 scale with week’s performance of 10.33%.

 

About Blake Escott

Blake Escott holds junior writer position in SWR. Before joining Streetwise Report, he was a freelance content Writer. He has high-level copywriting experience and particularly experienced in proofreading and editing. He covers news about different companies including all US market sectors. Interests: Commodities, Energy stocks, Sector-wise Stocks analysis, Utilities

Leave a Reply

Your email address will not be published. Required fields are marked *